Comparison of subcutaneous and intraperitoneal injection of d-luciferin for in vivo bioluminescence imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 5, 2009, Pages 771-779

  Inoue, Yusuke ^a   Kiryu, Shigeru ^a   Izawa, Kiyoko ^a   Watanabe, Makoto ^a   Tojo, Arinobu ^a   Ohtomo, Kuni ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bioluminescence imaging; Intraperitoneal injection; Luciferase; Mouse; Subcutaneous injection

Indexed keywords

BEETLE LUCIFERIN POTASSIUM SALT; LUCIFERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BIOLUMINESCENCE IMAGING; BONE MARROW; CAMERA; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEMATOLOGIC MALIGNANCY; IMAGE ANALYSIS; IMAGING SYSTEM; MOLECULAR IMAGING; MOUSE; NONHUMAN; PERITONEUM TUMOR; REPRODUCIBILITY; SIGNAL DETECTION; SPLEEN; SUBCUTANEOUS TISSUE TUMOR;

ANIMALS; BENZOTHIAZOLES; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LAMININ; LUCIFERASES, FIREFLY; LUMINESCENCE; LUMINESCENT MEASUREMENTS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; TIME FACTORS;

EID: 64649091261     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-1022-8     Document Type: Article

References (26)

1. M Edinger YA Cao YS Hornig DE Jenkins MR Verneris MH Bachmann 2002 Advancing animal models of neoplasia through in vivo bioluminescence imaging Eur J Cancer 38 2128 2136
2. CH Contag D Jenkins PR Contag RS Negrin 2000 Use of reporter genes for optical measurements of neoplastic disease in vivo Neoplasia 2 41 52
3. YA Cao AJ Wagers A Beilhack J Dusich MH Bachmann RS Negrin 2004 Shifting foci of hematopoiesis during reconstitution from single stem cells Proc Natl Acad Sci USA 101 221 226
4. A Nakajima CM Seroogy MR Sandora IH Tarner GL Costa C Taylor-Edwards 2001 Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis J Clin Invest 107 1293 1301
5. M Hutchens GD Luker 2007 Applications of bioluminescence imaging to the study of infectious diseases Cell Microbiol 9 2315 2322
6. JY Adams M Johnson M Sato F Berger SS Gambhir M Carey 2002 Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging Nat Med 8 891 897
7. H Carlsen G Alexander LM Austenaa K Ebihara R Blomhoff 2004 Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response Mutat Res 551 199 211
8. TF Massoud R Paulmurugan A De P Ray SS Gambhir 2007 Reporter gene imaging of protein-protein interactions in living subjects Curr Opin Biotechnol 18 31 37
9. M Edinger P Hoffmann CH Contag RS Negrin 2003 Evaluation of effector cell fate and function by in vivo bioluminescence imaging Methods 31 172 179
10. S Baba SY Cho Z Ye L Cheng JM Engles RL Wahl 2007 How reproducible is bioluminescent imaging of tumor cell growth? Single time point versus the dynamic measurement approach Mol Imaging 6 315 322
11. Z Paroo RA Bollinger DA Braasch E Richer DR Corey PP Antich 2004 Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden Mol Imaging 3 117 124
12. M Keyaerts J Verschueren TJ Bos LO Tchouate-Gainkam C Peleman K Breckpot 2008 Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: effect on intensity, time kinetics and repeatability of photon emission Eur J Nucl Med Mol Imaging 35 999 1007
13. KH Lee SS Byun JY Paik SY Lee SH Song YS Choe 2003 Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging Nucl Med Commun 24 1003 1009
14. S Zeamari G Rumping B Floot S Lyons FA Stewart 2004 In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats Br J Cancer 90 1259 1264
15. C Lu AA Kamat YG Lin WM Merritt CN Landen TJ Kim 2007 Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma Clin Cancer Res 13 4209 4217
16. 213Bi-radioimmunotherapy using bioluminescence imaging Eur J Nucl Med Mol Imaging 34 841 849
17. M Lockley M Fernandez Y Wang NF Li S Conroy N Lemoine 2006 Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin Cancer Res 66 989 998
18. MJ Bryant TL Chuah J Luff MF Lavin DG Walker 2008 A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line J Clin Neurosci 15 545 551
19. Y Zhang JP Bressler J Neal B Lal HE Bhang J Laterra 2007 ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging Cancer Res 67 9389 9397
20. S Gross D Piwnica-Worms 2005 Real-time imaging of ligand-induced IKK activation in intact cells and in living mice Nat Methods 2 607 614
21. Y Inoue A Tojo R Sekine Y Soda S Kobayashi A Nomura 2006 In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals Eur J Nucl Med Mol Imaging 33 557 565
22. EA Copelan EA McGuire 1995 The biology and treatment of acute lymphoblastic leukemia in adults Blood 85 1151 1168
23. S Li RL Ilaria Jr RP Million GQ Daley RA Van Etten 1999 The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity J Exp Med 189 1399 1412
24. Y Inoue K Izawa A Tojo Y Nomura R Sekine N Oyaizu 2007 Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy Exp Hematol 35 407 415
25. Y Inoue K Izawa S Kiryu S Kobayashi A Tojo K Ohtomo 2007 Bioluminescent evaluation of the therapeutic effects of total body irradiation in a murine hematological malignancy model Exp Hematol 36 1634 1641
26. W Wang WS El-Deiry 2003 Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model Cancer Biol Ther 2 196 202